265 related articles for article (PubMed ID: 31376172)
1. Amylin as a potential link between type 2 diabetes and alzheimer disease.
Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Riverol M; Marcilla I; de Andrea CE; Sánchez-Arias JA; Del Mar Carmona-Abellan M; Marti G; Erro ME; Martínez-Vila E; Tuñon MT; Luquin MR
Ann Neurol; 2019 Oct; 86(4):539-551. PubMed ID: 31376172
[TBL] [Abstract][Full Text] [Related]
2. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
[TBL] [Abstract][Full Text] [Related]
3. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
[TBL] [Abstract][Full Text] [Related]
4. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes.
Miklossy J; Qing H; Radenovic A; Kis A; Vileno B; Làszló F; Miller L; Martins RN; Waeber G; Mooser V; Bosman F; Khalili K; Darbinian N; McGeer PL
Neurobiol Aging; 2010 Sep; 31(9):1503-15. PubMed ID: 18950899
[TBL] [Abstract][Full Text] [Related]
5. Amylin deposition in the brain: A second amyloid in Alzheimer disease?
Jackson K; Barisone GA; Diaz E; Jin LW; DeCarli C; Despa F
Ann Neurol; 2013 Oct; 74(4):517-26. PubMed ID: 23794448
[TBL] [Abstract][Full Text] [Related]
6. Aβ efflux impairment and inflammation linked to cerebrovascular accumulation of amyloid-forming amylin secreted from pancreas.
Verma N; Velmurugan GV; Winford E; Coburn H; Kotiya D; Leibold N; Radulescu L; Despa S; Chen KC; Van Eldik LJ; Nelson PT; Wilcock DM; Jicha GA; Stowe AM; Goldstein LB; Powel DK; Walton JH; Navedo MF; Nystoriak MA; Murray AJ; Biessels GJ; Troakes C; Zetterberg H; Hardy J; Lashley T; Despa F
Commun Biol; 2023 Jan; 6(1):2. PubMed ID: 36596993
[TBL] [Abstract][Full Text] [Related]
7. Active-site environment of Cu bound amyloid β and amylin peptides.
Pal I; Roy M; Dey SG
J Biol Inorg Chem; 2019 Dec; 24(8):1245-1259. PubMed ID: 31620893
[TBL] [Abstract][Full Text] [Related]
8. Intraneuronal Amylin Deposition, Peroxidative Membrane Injury and Increased IL-1β Synthesis in Brains of Alzheimer's Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats.
Verma N; Ly H; Liu M; Chen J; Zhu H; Chow M; Hersh LB; Despa F
J Alzheimers Dis; 2016 May; 53(1):259-72. PubMed ID: 27163815
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
[TBL] [Abstract][Full Text] [Related]
10. Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.
Moreno-Gonzalez I; Edwards Iii G; Salvadores N; Shahnawaz M; Diaz-Espinoza R; Soto C
Mol Psychiatry; 2017 Sep; 22(9):1327-1334. PubMed ID: 28044060
[TBL] [Abstract][Full Text] [Related]
11. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease.
Oskarsson ME; Paulsson JF; Schultz SW; Ingelsson M; Westermark P; Westermark GT
Am J Pathol; 2015 Mar; 185(3):834-46. PubMed ID: 25700985
[TBL] [Abstract][Full Text] [Related]
12. Rapid, scalable assay of amylin-β amyloid co-aggregation in brain tissue and blood.
Kotiya D; Leibold N; Verma N; Jicha GA; Goldstein LB; Despa F
J Biol Chem; 2023 May; 299(5):104682. PubMed ID: 37030503
[TBL] [Abstract][Full Text] [Related]
13. Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.
Ashraf GM; Greig NH; Khan TA; Hassan I; Tabrez S; Shakil S; Sheikh IA; Zaidi SK; Akram M; Jabir NR; Firoz CK; Naeem A; Alhazza IM; Damanhouri GA; Kamal MA
CNS Neurol Disord Drug Targets; 2014; 13(7):1280-93. PubMed ID: 25230234
[TBL] [Abstract][Full Text] [Related]
14. Hyperamylinemia as a risk factor for accelerated cognitive decline in diabetes.
Ly H; Despa F
Expert Rev Proteomics; 2015; 12(6):575-7. PubMed ID: 26503000
[TBL] [Abstract][Full Text] [Related]
15. Transactive DNA Binding Protein 43 Rather Than Other Misfolded Proteins in the Brain is Associated with Islet Amyloid Polypeptide in Pancreas in Aged Subjects with Diabetes Mellitus.
Leino M; Popova SN; Alafuzoff I
J Alzheimers Dis; 2017; 59(1):43-56. PubMed ID: 28582864
[TBL] [Abstract][Full Text] [Related]
16. Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells.
Bharadwaj P; Solomon T; Sahoo BR; Ignasiak K; Gaskin S; Rowles J; Verdile G; Howard MJ; Bond CS; Ramamoorthy A; Martins RN; Newsholme P
Sci Rep; 2020 Jun; 10(1):10356. PubMed ID: 32587390
[TBL] [Abstract][Full Text] [Related]
17. The pancreas-brain axis: insight into disrupted mechanisms associating type 2 diabetes and Alzheimer's disease.
Desai GS; Zheng C; Geetha T; Mathews ST; White BD; Huggins KW; Zizza CA; Broderick TL; Babu JR
J Alzheimers Dis; 2014; 42(2):347-56. PubMed ID: 24858405
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes mellitus and biomarkers of neurodegeneration.
Moran C; Beare R; Phan TG; Bruce DG; Callisaya ML; Srikanth V;
Neurology; 2015 Sep; 85(13):1123-30. PubMed ID: 26333802
[TBL] [Abstract][Full Text] [Related]
19. Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease.
Zhu H; Xue X; Wang E; Wallack M; Na H; Hooker JM; Kowall N; Tao Q; Stein TD; Wolozin B; Qiu WQ
Neuropharmacology; 2017 Jun; 119():170-181. PubMed ID: 28363773
[TBL] [Abstract][Full Text] [Related]
20. Bloodborne Pancreatic Amylin, A Therapeutic Target for Alzheimer's Disease.
Despa F
Curr Alzheimer Res; 2023 Feb; ():. PubMed ID: 36803745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
